Medical Weight Loss for Burlington, Vermont Residents

Burlington, Vermont residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Burlington through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

No clinic to drive to in Burlington: Dr. Anjmun Sharma reviews your health by video, and your compounded semaglutide or tirzepatide ships straight to your Vermont address. Nothing to pick up, no waiting room, no local office needed. Doctor review just $119 (medication separate).

Why Burlington Residents Choose New Hope Weight Loss

Trust comes down to who is responsible and whether the price is straight, and on both counts New Hope gives Burlington a clear answer. Dr. Anjmun Sharma, MD personally oversees your care, the pricing is flat and posted, and the whole program reaches you by telehealth from Costa Mesa with no insurance required and no distance surcharge. A named physician, an honest number, and care that comes to you across Vermont. That is the entire promise, and we keep it.

Burlington is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

New Hope Weight Loss is based in Costa Mesa, yet a patient in Burlington sees the same doctor, takes the same approach, and pays the same prices, all through telehealth across Vermont. We care for patients throughout Downtown, the Hill Section, the Old North End, the South End, and Chittenden County. Every prescription is reviewed and authorized by Dr. Anjmun Sharma, MD, before anything is sent to your address in Vermont.

Patients on the outskirts of Vermont get the same flat pricing, the same physician, and the same fast start as those near the center of Burlington. Getting started in Burlington is simple: a Vermont licensed physician reviews your health history for $119, and your medication is billed separately if you are approved. Even in the rural reaches of Vermont, New Hope Weight Loss reaches patients by secure telehealth from our Costa Mesa, California clinic, so distance never limits your physician-supervised care.

GLP-1 Weight Loss Programs Available

Two GLP-1 paths, one plan built around you

The 90-Day Metabolic Reset uses semaglutide, the same active ingredient in Wegovy and Ozempic. From $166 a month, or $499 for the full 90 days, it pairs medication with monthly check-ins. Branded-drug trials showed average loss of about 15 to 17 percent. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary from person to person.

Want a stronger option? Ask about tirzepatide

From $233 a month, tirzepatide combines GLP-1 and GIP action. Trial participants on qualifying doses saw up to 22.5 percent body-weight loss, a top-dose number rather than the average. It carries the same active ingredient as Mounjaro and Zepbound.

Your $119 physician review comes first. Medication is billed separately. HSA, FSA, Klarna, and Affirm are all welcome for Burlington patients.

How Telehealth Works for Burlington

Here is how the whole thing works, start to finish, for anyone in Burlington.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Burlington address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Burlington

I am searching for weight loss care near Burlington. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Burlington, Vermont connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Burlington?

Not at all. The telehealth format covers Burlington patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Burlington in cold-pack packaging built to keep it cool and stable.

What are the program costs for Burlington patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Burlington patients face no distance surcharge.

What areas of Burlington do you serve?

We serve patients from across Burlington by telehealth, including Downtown, the Hill Section, the Old North End, the South End, and Chittenden County.

Is bilingual (Spanish) telehealth care available for Burlington patients?

Yes. Anamaria Schmidt, our bilingual clinical coordinator, handles calls, WhatsApp, and Spanish-language consultations, with Dr. Sharma supervising every case. The full telehealth program, intake, consultation, and follow-up, is available in Spanish for Burlington patients.

Burlington Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Burlington, Vermont by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.